Abstract: The invention relates to a biocompatible, low-viscosity, radiation-curable formulation for producing medical products, in particular adaptive ear pieces, otoplastic parts, shells or ear parts, by means of PNP methods or stereolithographic methods. Said formulation comprises: a) 15-60 wt. % of a monomeric or oligomeric dimethacrylate based on bisphenol A or bisphenol F; b) 0-50 wt. % one or more monomeric or oligomeric urethane (meth)acrylates with a functionality n<4, a viscosity <30 Pa s and a molecular weight <3500; c) 2-25 wt. % of a monomeric, aliphatic or cycloaliphatic dimethacrylate with a viscosity <3 Pa s; d) 2-35 wt. % of an iminooxadiazone dion derivative, characterised by 3 methacrylate and/or acrylate functions; 0-15 wt. % one or more monofunctional methacrylates; f) 0.5-6 wt. % of a photo initiator or a combination of photo initiators, whose absorption lies in the wavelength range of the laser beam that is used or the irradiation source; g) 0-0.5 wt.

Abstract: A two-component addition-crosslinking silicone comprises (a) 0.1-70% by weight polyorganosiloxanes containing at least two unsaturated groups in the molecule; (b) 0.1-15% by weight polyorganohydrogensiloxanes containing at least two SiH groups in the molecule; (c) 0.01-2.0% by weight noble metal catalyst; and (d) 0.1-5% by weight of a non-toxic antimicrobial additive or a combination of at least two non-toxic antimicrobial additives.

Abstract: A biocompatible, low-viscosity, radiation-curable composition for producing antimicrobial earpieces contains: a) 20-75 wt. % of one or a plurality of monomeric/oligomeric urethane(meth)acrylates having an acrylate functionality of <4, viscosity <30 Pa s, and molecular weight <3500; b) 5-45 weight % of a monomeric or oligomeric dimethacrylate of bisphenol A or bisphenol F and or of a monomeric aliphatic or cycloaliphatic di(meth)acrylate having a viscosity <6 Pa s; c) 2.5-25 weight % of a cross-linking monomeric or oligomeric component containing 4 methacrylate and/or acrylate functionalities; d) 0-15 wt. % of one or a plurality of monofunctional (meth)acrylates; e) 0.01-5 wt. % of one or a combination of antimicrobially active glass fillers and silver particles; and f) 0.5-6 wt. % of one or a plurality of photoinitiators whose absorption is in the wavelength range of an ND:YVO4 laser beam used or of an actinic radiation source used to promote free radical formation.

Abstract: The invention relates to a biocompatible, low-viscosity, radiation-curable formulation for producing medical products, in particular adaptive ear pieces, otoplastic parts, shells or ear parts, by means of PNP methods or stereolithographic methods. Said formulation comprises: a) 15-60 wt. % of a monomeric or oligomeric dimethacrylate based on bisphenol A or bisphenol F; b) 0-50 wt. % one or more monomeric or oligomeric urethane (meth)acrylates with a functionality n<4, a viscosity <30 Pa s and a molecular weight <3500; c) 2-25 wt. % of a monomeric, aliphatic or cycloaliphatic dimethacrylate with a viscosity <3 Pa s; d) 2-35 wt. % of an iminooxadiazone dion derivative, characterised by 3 methacrylate and/or acrylate functions; 0-15 wt. % one or more monofunctional methacrylates; f) 0.5-6 wt. % of a photo initiator or a combination of photo initiators, whose absorption lies in the wavelength range of the laser beam that is used or the irradiation source; g) 0-0.5 wt.

Abstract: The invention relates to a biocompatible, low-viscous, radiation curable formulation, particularly for use in stereolithography, for use in medical technology, in particular, for producing earpieces, containing: a) 55-95% by weight of a monomeric or oligomeric dimethacrylate based on bisphenol A or bisphenol F; b) 0-20% by weight of a urethane methacrylate having a functionality of n<4 and a viscosity<15 Pa s; c) 2-15% by weight of a monomeric aliphatic or cycloaliphatic dimethacrylate having a viscosity<5 Pa s; d) 0-15% by weight of a monofunctional methacrylate having a viscosity<3 Pa s; e) 0.5-6% by weight of a photoinitiator or a combination of a number of photoinitiators whose absorption is located within the wavelength range of the laser beam used; f) 0.

Abstract: The invention suggests a biocompatible, low-viscosity, radiation-curable composition for producing antimicrobial medical products, in particular earpieces, by means of PNP or generative production methods, containing: a) 0-75 wt. % of one or a plurality of monomeric/oligomeric urethane(meth)acrylates having a functionality of n <4, viscosity <30 Pa s, and molecular weight <3500; b) 0-5 wt. % of a monomeric or oligomeric dimethacrylate based on bisphenol A or bisphenol F and or of a monomeric aliphatic or cycloaliphatic di(meth)acrylate having a viscosity <6 Pa s; c) 0-25 wt. % of an n-fold cross-linking monomeric or oligomeric component, characterized by n3 3 meth- and/or acrylate functions; d) 0-15 wt. % of one or a plurality of monofunctional (meth)acrylates; e) 0.01-5 wt. % of one or a combination of antimicrobial additives from the groups of antimicrobially active glass fillers or silver particles; f) 0.5-6 wt.

Abstract: A two-component addition-crosslinking silicone comprises (a) 0.1-70% by weight polyorganosiloxanes containing at least two unsaturated groups in the molecule; (b) 0.1-15% by weight polyorganohydrogensiloxanes containing at least two SiH groups in the molecule; (c) 0.01-2.0% by weight noble metal catalyst; and (d) 0.1-5% by weight of a non-toxic antimicrobial additive or a combination of at least two non-toxic antimicrobial additives.